SOURCE: Linkage Biosciences

October 16, 2007 10:00 ET

Linkage Biosciences Completes Seed Financing

SAN FRANCISCO, CA--(Marketwire - October 16, 2007) - Linkage Biosciences Inc., a developer of molecular diagnostics products designed to streamline complex genetic testing, has completed a financing round led by Greenhouse Capital Partners LP, a seed-stage venture capital firm, which brings the total funding raised thus far to approximately $1 million. Linkage Biosciences said the new funds will be used to accelerate development of its initial line of diagnostic products for solid organ and stem cell transplantation.

"Our strategy is to deliver products that solve important clinical needs in ways that are faster and less labor intensive than ever before," said Zachary Antovich, President and CEO of Linkage Biosciences. "With our proprietary technology and strong business and scientific teams, we are confident we have the resources to make a lasting impact in our market."

Linkage Biosciences' Scientific Advisory Board includes:

--  F. Carl Grumet, M.D., Emeritus Professor of Pathology and Emeritus
    Director Stanford Histocompatibility Laboratory, Stanford University
--  Clifford Lowell, M.D., Ph.D., Professor and Chair of the Department of
    Laboratory Medicine, University of California, San Francisco
--  Rade Drmanac, Ph.D., Chief Science Officer of Complete Genomics
--  David Ginzinger, Ph.D., Acting Vice President Research and Development
    at Linkage Biosciences
    

"A pioneering entrant in the diagnostics-testing space, Linkage Biosciences has what we believe is a rare and promising opportunity to re-define today's standards and significantly grow this market," said Peter D. Henig, Managing Partner of Greenhouse Capital Partners. "We look forward to helping the company enhance its technology development and time to market, and to also structurally prepare them for subsequent financing rounds."

Linkage Biosciences also announced that Mr. Henig has joined the company's board of directors.

About Greenhouse Capital Partners

Greenhouse Capital Partners, a seed-stage venture capital firm dedicated to fostering innovation in cleantech and select other emerging technologies, provides strategic guidance and seed and Series A financing to companies at their earliest stages of creation. Founded in January 2006, Greenhouse Capital is located in Sausalito, Calif. For more information, please visit www.greenhousecapital.net.

About Linkage Biosciences Inc.

Linkage Biosciences Inc. is a pioneering developer of molecular diagnostics products designed to streamline complex genetic testing. The company's initial focus is on diagnostic products for solid organ and stem cell transplantation. For more information, please visit www.linkagebio.com.